Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital, Angers
Essen Biotech
Mayo Clinic
Celgene
Celgene
Azienda Ospedaliera Universitaria Mater Domini, Catanzaro
First Affiliated Hospital of Wenzhou Medical University
Shenzhen BinDeBio Ltd.
Mirna Therapeutics, Inc.
Rutgers, The State University of New Jersey
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Case Comprehensive Cancer Center